APOA1 and type 2 diabetes mellitus: This study demonstrates that L-4F, an economical ApoA-I mimetic peptide, reduces neurovascular and WM damage via reducing proinflmammatory factors RAGE/HMGB-1 and TNFα/PAI-1 in the ischemic brain in db/db T2DM stroke mice.